AAAAAA

   
Results: 1-17 |
Results: 17
Thrombolytic therapy and mortality
Authors: Thiemann, DR Coresh, J Schulman, SP Gerstenblith, G Powe, NR
Citation: Dr. Thiemann et al., Thrombolytic therapy and mortality, LANCET, 357(9265), 2001, pp. 1367-1367
Upregulation of the nitric oxide-cGMP pathway in aged myocardium - Physiological response to L-arginine
Authors: Zieman, SJ Gerstenblith, G Lakatta, EG Rosas, GO Vandegaer, K Ricker, KM Hare, JM
Citation: Sj. Zieman et al., Upregulation of the nitric oxide-cGMP pathway in aged myocardium - Physiological response to L-arginine, CIRCUL RES, 88(1), 2001, pp. 97-102
Case 7: Isolated systolic hypertension; Diastolic dysfunction - Level 2
Authors: Washington, E Gourley, DR Carmen, M Gerstenblith, G Reeder, CE Ross, S Womeodu, R
Citation: E. Washington et al., Case 7: Isolated systolic hypertension; Diastolic dysfunction - Level 2, AM J M CARE, 6(3), 2000, pp. S150
Case 8: Post-myocardial infarction; Asymptomatic left ventricular dysfunction - Level 1
Authors: Washington, E Gourley, DR Carmen, M Gerstenblith, G Reeder, CE Ross, S Womeodu, R
Citation: E. Washington et al., Case 8: Post-myocardial infarction; Asymptomatic left ventricular dysfunction - Level 1, AM J M CARE, 6(3), 2000, pp. S153
Case 9: Idiopathic cardiomyopathy with decompensated congestive heart failure - Level 2
Authors: Washington, E Gourley, DR Carmen, M Gerstenblith, G Reeder, CE Ross, S Womeodu, R
Citation: E. Washington et al., Case 9: Idiopathic cardiomyopathy with decompensated congestive heart failure - Level 2, AM J M CARE, 6(3), 2000, pp. S156
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years
Authors: Thiemann, DR Coresh, J Schulman, SP Gerstenblith, G Oetgen, WJ Powe, NR
Citation: Dr. Thiemann et al., Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years, CIRCULATION, 101(19), 2000, pp. 2239-2246
Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals
Authors: Chen, CH Nakayama, M Talbot, M Nevo, E Fetics, B Gerstenblith, G Becker, LC Kass, DA
Citation: Ch. Chen et al., Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals, J AM COL C, 33(6), 1999, pp. 1602-1609
Hemodynamic effects of unloading the old heart
Authors: Nussbacher, A Gerstenblith, G O'Connor, FC Becker, LC Kass, DA Schulman, SP Fleg, JL Lakatta, EG
Citation: A. Nussbacher et al., Hemodynamic effects of unloading the old heart, AM J P-HEAR, 277(5), 1999, pp. H1863-H1871
Neurogenic ST depression in stroke
Authors: Chua, HC Sen, S Cosgriff, RF Gerstenblith, G Beauchamp, NJ Oppenheimer, SM
Citation: Hc. Chua et al., Neurogenic ST depression in stroke, CLIN NEUROL, 101(1), 1999, pp. 44-48
High extracellular K+ during hypoxic preconditioning episodes attenuates the post-ischemic contractile and ionic benefits of preconditioning
Authors: Baumgarten, KM Gerstenblith, G Weiss, RG
Citation: Km. Baumgarten et al., High extracellular K+ during hypoxic preconditioning episodes attenuates the post-ischemic contractile and ionic benefits of preconditioning, J MOL CEL C, 31(1), 1999, pp. 203-213
Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity
Authors: Weiss, RG Mejia, MA Kass, DA DiPaula, AF Becker, LC Gerstenblith, G Chacko, VP
Citation: Rg. Weiss et al., Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity, J CLIN INV, 103(5), 1999, pp. 739-746
New developments in the treatment of hypertension: What the HOT study means to JNC-VI
Authors: Gerstenblith, G Schulman, S
Citation: G. Gerstenblith et S. Schulman, New developments in the treatment of hypertension: What the HOT study means to JNC-VI, AM J M CARE, 4(12), 1998, pp. S719-S721
Hypertension in the older patient
Authors: Gerstenblith, G Schulman, S Brunton, S Wagner, SL Messerli, FH Wilson, M Jacobs, RP Shepard, DS Whittlesey, D
Citation: G. Gerstenblith et al., Hypertension in the older patient, AM J M CARE, 4(12), 1998, pp. S722-S732
The Hypertension Optimal Treatment (HOT) study: Implications for hypertension management and the J-shape curve
Authors: Schulman, S Brunton, S Shepard, DS Jacobs, RP Gerstenblith, G Wilson, M Wagner, SL
Citation: S. Schulman et al., The Hypertension Optimal Treatment (HOT) study: Implications for hypertension management and the J-shape curve, AM J M CARE, 4(12), 1998, pp. S733-S740
Barriers to guideline adherence
Authors: Cabana, M Brunton, S Jacobs, RP Wagner, SL Shepard, DS Gerstenblith, G Hodgkin, D
Citation: M. Cabana et al., Barriers to guideline adherence, AM J M CARE, 4(12), 1998, pp. S741-S748
Hypertension and managed care
Authors: Jacobs, RP Wilson, M Gerstenblith, G Brunton, S Wagner, SL Whittlesey, D Cabana, M Wagner, SL
Citation: Rp. Jacobs et al., Hypertension and managed care, AM J M CARE, 4(12), 1998, pp. S749-S756
beta-blockers as first-line therapy for hypertension in the elderly
Authors: Messerli, FH Schulman, S Gerstenblith, G Brunton, S Jacobs, RP Shepard, DS Cabana, M Wilson, M
Citation: Fh. Messerli et al., beta-blockers as first-line therapy for hypertension in the elderly, AM J M CARE, 4(12), 1998, pp. S757-S764
Risultati: 1-17 |